"Don't delay your care: you can schedule in-office appointments or video visits with NYU Langone doctors online. Every precaution is in place to ensure our facilities are safe so you can get the care you need. Visit our website for more details."

During the past decade, NYU Langone Medical Center, Tisch Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NYU Langone Medical Center, Tisch Hospital" #1 sponsor was "NYU Langone Health" with 13 trials, followed by "Pfizer" with 4 trials sponsored, "Albert Einstein College of Medicine" with 1 trials sponsored, "Mayo Clinic" with 1 trials sponsored and "Penumbra Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Medical Center, Tisch Hospital" #1 collaborator was "Medical University of South Carolina" with 2 trials as a collaborator, "Alexion, AstraZeneca Rare Disease" with 1 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Ara Parseghian Medical Research Fund" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "NYU Langone Medical Center, Tisch Hospital" are "Breast Cancer" (4 trials), "Ovarian Cancer" (3 trials), "Prostate Cancer" (2 trials), "Stroke" (2 trials) and "Acid Sphingomyelinase Deficiency" (1 trials). Many other conditions were trialed in "NYU Langone Medical Center, Tisch Hospital" in a lesser frequency.

Most popular intervention types in "NYU Langone Medical Center, Tisch Hospital" are "Drug" (15 trials), "Device" (4 trials), "Other" (3 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adjuvant Chemoradiation therapy" (1 trials), "Anticoagulant Therapy" (1 trials), "Appendectomy" (1 trials) and "Bacillus Calmette-Guerin" (1 trials). Other intervention names were less common.

The vast majority of trials in "NYU Langone Medical Center, Tisch Hospital" are 20 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 9 active trials in "NYU Langone Medical Center, Tisch Hospital". 1 are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in NYU Langone Medical Center, Tisch Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in NYU Langone Medical Center, Tisch Hospital, 7 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".